Catalyst Wire Dossier Catalyst Wire Dossier

INTERCEPT Platelets

amotosalen-treated platelets · Cerus Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INTERCEPT Platelets, covering 2010-04-14 to 2010-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days [Phase 3]

See pricing